Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Wave Life Sciences Ltd (NASDAQ: WVE) was $7.7 for the day, up 10.79% from the previous closing price of $6.95. In other words, the price has increased by $10.79 from its previous closing price. On the day, 1.7 million shares were traded. WVE stock price reached its highest trading level at $7.72 during the session, while it also had its lowest trading level at $6.95.
Ratios:
Our analysis of WVE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.95 and its Current Ratio is at 2.95. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.09.
On April 29, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $10.
On April 08, 2025, Wedbush started tracking the stock assigning a Outperform rating and target price of $18.Wedbush initiated its Outperform rating on April 08, 2025, with a $18 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 13 ’25 when Verdine Gregory L. sold 30,000 shares for $6.95 per share. The transaction valued at 208,500 led to the insider holds 282,517 shares of the business.
GREGORY VERDINE bought 30,000 shares of WVE for $216,000 on Jun 13 ’25. On Mar 20 ’25, another insider, HENRY CHRISTIAN O, who serves as the Director of the company, sold 10,500 shares for $9.77 each. As a result, the insider received 102,574 and left with 16,115 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WVE now has a Market Capitalization of 1197835136 and an Enterprise Value of 790269888. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.41 while its Price-to-Book (P/B) ratio in mrq is 6.91. Its current Enterprise Value per Revenue stands at 7.531 whereas that against EBITDA is -6.477.
Stock Price History:
The Beta on a monthly basis for WVE is -0.97, which has changed by 0.2984823 over the last 52 weeks, in comparison to a change of 0.12153554 over the same period for the S&P500. Over the past 52 weeks, WVE has reached a high of $16.74, while it has fallen to a 52-week low of $5.04. The 50-Day Moving Average of the stock is 14.02%, while the 200-Day Moving Average is calculated to be -23.78%.
Shares Statistics:
WVE traded an average of 1.33M shares per day over the past three months and 1269790 shares per day over the past ten days. A total of 154.09M shares are outstanding, with a floating share count of 124.26M. Insiders hold about 20.12% of the company’s shares, while institutions hold 80.74% stake in the company. Shares short for WVE as of 1749772800 were 14881762 with a Short Ratio of 11.23, compared to 1747267200 on 15449847. Therefore, it implies a Short% of Shares Outstanding of 14881762 and a Short% of Float of 13.05.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
